资讯
The Director General of the National Agency for Food and Drug Administration and Control (NAFDAC), Prof. Mojisola Adeyeye, has called on Nigerian pharmaceutical manufacturers and universities to colla ...
Those were some of the insights Commencement speaker Chris Gheysens, chairman and CEO of Wawa, shared with Rowan University’s ...
Clover Health Investments posted strong Q1 growth, with rising membership, CMS tailwinds, and path to profitability by FY ...
11 小时
Tribune Online on MSNNAFDAC DG seeks industry-academia synergy to boost local pharmaceutical productionThe Director General of the National Agency for Food and Drug Administration and Control (NAFDAC), Prof. Mojisola Adeyeye, has called for stronger NAFDAC pharmaceutical R&D collaboration between ...
The Director General of the National Agency for Food and Drug Administration and Control (NAFDAC), Prof. Mojisola Adeyeye, ...
14 小时Opinion
TheJournal.ie on MSNOpinion: Normalising the corporate funding of higher education in Ireland is a dangerous gameProfessor Jennie C Stephens and Conchúr Ó Maonaigh of Maynooth University investigate how much corporate money is being used ...
A global study led by McGill University estimates that 8,500 tonnes of antibiotics enter river systems annually, mostly from ...
Lantern Pharma, Inc. engages in the development of drugs through leveraging artificial intelligence, machine learning, and genomic data. Its portfolio includes LP-100, LP-300, and LP-184.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果